Publications
Suspected paracetamol overdose in Monrovia, Liberia: a matched case-control study.
BACKGROUND: A cluster of cases of unexplained multi-organ failure was reported in children at Bardnesville Junction Hospital (BJH), Monrovia, Liberia.
The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis.
BACKGROUND: Tens of millions of children are exposed to Mycobacterium tuberculosis globally every year; however, there are no contemporary estimates of the risk of developing tuberculosis in exposed children.
Field challenges to measles elimination in the Democratic Republic of the Congo.
BACKGROUND: During a measles epidemic, the Ministry of Public Health (MOH) of the Democratic Republic of the Congo conducted supplementary immunization activities (2016-SIA) from August 28-September 3, 2016 throughout Maniema Province.
Alternative observational designs to estimate the effectiveness of one dose of oral cholera vaccine in Lusaka, Zambia.
We conducted a matched case-control (MCC), test-negative case-control (TNCC) and case-cohort study in 2016 in Lusaka, Zambia, following a mass vaccination campaign. Confirmed cholera cases served as cases in all three study designs.
Energy needs in the treatment of uncomplicated severe acute malnutrition: Secondary analysis to optimize delivery of ready-to-use therapeutic foods.
Outpatient therapeutic feeding protocols for the treatment of uncomplicated severe acute malnutrition in children were initially based on weight gain data from inpatient settings and expert knowledge of the physiological requirements during recovery.
Intrahousehold management and use of nutritional supplements during the hunger gap in Maradi region, Niger: a qualitative study.
Background: Nutritional supplements are used for preventing and treating childhood malnutrition.
Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan: a modelling analysis.
BACKGROUND: The WHO elimination strategy for hepatitis C virus advocates scaling up screening and treatment to reduce global hepatitis C incidence by 80% by 2030, but little is known about how this reduction could be achieved and the c